Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
N/A
75,000 Added 59.24%
201,600 $35,000
Q2 2022

Aug 15, 2022

SELL
N/A
-160,000 Reduced 55.83%
126,600 $76,000
Q4 2021

Feb 14, 2022

BUY
N/A
81,000 Added 39.4%
286,600 $748,000
Q3 2021

Nov 15, 2021

BUY
N/A
117,000 Added 132.05%
205,600 $639,000
Q2 2021

Aug 16, 2021

SELL
N/A
-24,000 Reduced 21.31%
88,600 $330,000
Q1 2021

May 17, 2021

SELL
N/A
-15,000 Reduced 11.76%
112,600 $390,000
Q4 2020

Feb 16, 2021

SELL
N/A
-25,000 Reduced 16.38%
127,600 $429,000
Q2 2020

Aug 14, 2020

SELL
N/A
-30,900 Reduced 16.84%
152,600 $702,000
Q1 2020

May 15, 2020

BUY
N/A
9,100 Added 5.22%
183,500 $607,000
Q4 2019

Feb 14, 2020

BUY
N/A
174,400 New
174,400 $1.07 Million

About PHASEBIO PHARMACEUTICALS INC C


  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.